Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Literature
1.
Sapkota HR, Nune A (2022) Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol 41:337–348CrossRef
2.
3.
Ramos-Casals M, Brito-Zerón P, Mariette X (2021) Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 17:315–332CrossRef
4.
Bastard P, Rosen LB, Zhang Q et al (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370:eabd4585CrossRef
5.
Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370:eabd4570CrossRef
6.
Jog NR, Young KA, Munroe ME et al (2019) Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk-individuals. Ann Rheum Dis 78:1235–1241CrossRef
7.
Marino Gammazza A, Légaré S, Lo Bosco G et al (2020) Human molecular chaperons share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Cell Stress Chaperons 25:737–741CrossRef
8.
Metadata
Title
Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
Authors
Alexandros A. Drosos
Eleftherios Pelechas
Paraskevi V. Voulgari
Publication date
01-03-2022
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 3/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-022-06092-4

Other articles of this Issue 3/2022

Clinical Rheumatology 3/2022 Go to the issue

Original Article

Analysis of children with Henoch–Schonlein purpura secondary to infection

Original Article

Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study

Brief Report

Different epidemiologic profiles of systemic vasculitis between Brazil and Peru—preliminary results in two referral centers from both countries

Original Article

Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases

Letters of Biomedical and Clinical Research

Correlation between atmospheric variables and strength of squeeze test in patients with hand arthralgia

Letter to the Editor

In response to comment on “Hip involvement in children with enthesitis-related arthritis (ERA) is associated with poor outcomes in adulthood” by Ferjani H L et al. 
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits